An Antisense Oligonucleotide-Loaded Blood–Brain Barrier Penetrable Nanoparticle Mediating Recruitment of Endogenous Neural Stem Cells for the Treatment of Parkinson’s Disease-Reference-Cited by-同舟云学术

An Antisense Oligonucleotide-Loaded Blood–Brain Barrier Penetrable Nanoparticle Mediating Recruitment of Endogenous Neural Stem Cells for the Treatment of Parkinson’s Disease

Published:2023-01-23 Issue:5 Volume:17 Page:4414-4432
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Sun Yuting¹,Kong Jianglong¹^ORCID,Ge Xiaohan¹,Mao Meiru¹,Yu Hongrui¹,Wang Yi¹²^ORCID

Affiliation:

1. College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou310058, P.R. China

2. Ningbo Research Institute, Zhejiang University, Ningbo315100, P.R. China

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.2c09752

Reference75 articles.

1. Brief update on endocytosis of nanomedicines

2. Zein/cellulose acetate hybrid nanofibers: Electrospinning and characterization

3. Primary Structure of a Proline-Rich Zein and Its cDNA

4. Particle shape enhances specificity of antibody-displaying nanoparticles

5. The proton sponge hypothesis: Fable or fact?

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential application of aptamers combined with DNA nanoflowers in neurodegenerative diseases;Ageing Research Reviews;2024-09

2. Harnessing extracellular vesicle membrane for gene therapy: EVs-biomimetic nanoparticles;Colloids and Surfaces B: Biointerfaces;2024-07

3. An Overview on the Physiopathology of the Blood–Brain Barrier and the Lipid-Based Nanocarriers for Central Nervous System Delivery;Pharmaceutics;2024-06-22

4. Understanding the (epi)genetic dysregulation in Parkinson's disease through an integrative brain competitive endogenous RNA network;Mechanisms of Ageing and Development;2024-06

5. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma;Journal of Nanobiotechnology;2024-05-17